内耳疾病的基因疗法:下一个目标
Hinrich Staecker1, Christoph Arnoldner2
1Department of Otolaryngology Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, Kansas, USA.
Current opinion in otolaryngology & head and neck surgery
|September 4, 2025
概括
基因疗法对治疗遗传性听力损失, 遗传性听力损失和主导性疾病对基因治疗的干预构成挑战.
科学领域:
- 耳鼻喉科
- 遗传学
- 分子生物学
背景情况:
- 听力损失的原因有100多种.
- 成功的奥托弗林基因疗法试验突出了潜在的治疗方法.
- 基因疗法是治疗遗传疾病的快速发展领域.
研究的目的:
- 用目前的基因治疗技术来确定可治疗的遗传性听力损失疾病.
- 评估各种遗传性听力损失的基因替代和基因编辑的可行性.
- 讨论影响听力损失基因疗法的关键因素.
主要方法:
- 审查当前的基因疗法技术及其对遗传性听力损失的适用性.
- 疾病特征分析,包括受影响的细胞类型,基因大小和发病率.
- 对不同基因突变的基因替代与基因编辑策略的考虑.
主要成果:
- 在出生后到成年时,遗传性听力损失与残留的向细胞是最佳的向.
- 像DFNB8和某些DFNB1突变这样的疾病有可能通过基因治疗来治疗.
- 目前对于衰退性疾病的基因替代比对主导性疾病的基因编辑更为可行.
结论:
- 遗传性听力损失目前是基因疗法的最有前途的目标.
- 在子宫内造成严重或严重的听力损失尚未得到治疗.
- 预计衰减性听力损失的基因替代将在主导形式的基因编辑之前推进.
相关概念视频
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Microorganisms in Medicine and Therapeutics
311
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
311
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


